Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409464 | 0.95 | HSD11B1 (0.32) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL250942 | 0.93 | HSD11B1 (0.35) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL249375 | 0.93 | HSD11B1 (0.35) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL15466914 | 0.87 | ALDH1A1 (0.30) | ALDH1A1GAATDP1 | |
| SCHEMBL28367030 | 0.87 | EPAS1 (0.30) | — | |
| SCHEMBL15467476 | 0.86 | — | — | |
| SCHEMBL15466703 | 0.83 | ALDH1A1 (0.32) | ALDH1A1GAATDP1 | |
| Nitric Acid SCHEMBL31522378 | 0.81 | HSD11B1 (0.33) | KDM4ELMNA | |
| SCHEMBL24229290 | 0.80 | ALDH1A1 (0.31) | ALDH1A1GAATDP1 | |
| SCHEMBL961444 | 0.79 | KDM4E (0.39) | KDM4ELMNAALDH1A1GAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6476240-B2 | POLYMERS DERIVED FROM AN UNSATURATED FUSED CYCLIC HYDROCARBON (SUCH AS PERHYDRO-2,3-DIDEHYDRO-1,4:5,8-DIMETHANONAPHTHALENE) JOINED BY A LINKER TO AN ESTER GROUP HAVING ONE OR TWO PROTECTED HYDROXYLS; USE AS PHOTORESIST | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| US-20020042531-A1 | Polymers derived from an unsaturated fused cyclic hydrocarbon (such as perhydro-2,3-didehydro-1,4:5,8-dimethanonaphthalene) joined by a linker to an ester group having one or two protected hydroxyls; use as photoresist | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6331602-B1 | Monomer and a polymer obtained therefrom | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-18 | — | — | US | disclosed |
| US-6160068-A | Monomer and a polymer obtained therefrom | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-12 | — | — | US | disclosed |
| US-6143472-A | Resist composition and a method for formation of a pattern using the composition | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-0918048-A1 | A novel monomer and a polymer obtained therefrom | Wako Pure Chemical Industries, Ltd. (JP) | 1999-05-26 | — | — | EP | disclosed |
| US-4033982-A | REACTING NORBORNENES WITH SULFUR | GENERAL ELECTRIC COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042531-A1 | Polymers derived from an unsaturated fused cyclic hydrocarbon (such as perhydro-2,3-didehydro-1,4:5,8-dimethanonaphthalene) joined by a linker to an ester group having one or two protected hydroxyls; use as photoresist | AHR, DHCR24, FPR1 | KDM4E 1608/4885LMNA 1686/4885ALDH1A1 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.